Filing Details
- Accession Number:
- 0001209191-14-072478
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-02 18:42:52
- Reporting Period:
- 2014-12-02
- Filing Date:
- 2014-12-02
- Accepted Time:
- 2014-12-02 18:42:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1354434 | Jr C Ronald Renaud | C/O Akebia Therapeutics, Inc. 245 First Street, Suite 1100 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-02 | 5,000 | $11.92 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in this Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.85 to $11.95, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Billionaire Hedge Funds
